Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis

Brain Research Bulletin

Volumn 46, Issue 6, 1998, Pages 541-546

  Jaworowicz Jr , David J ^a   Korytko, Peter J ^a   Lakhman, Sukhwinder Singh ^a   Boje, Kathleen M K ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Blood brain barrier; Inflammatory mediators; Lipopolysaccharides; Meningitis; Nitric oxide; Permeability kinetics; Prostaglandin E2

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; INFLAMMATION; MALE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CARBON RADIOISOTOPES; CEREBELLUM; CORPUS STRIATUM; DINOPROSTONE; DISEASE MODELS, ANIMAL; FRONTAL LOBE; HIPPOCAMPUS; LEUKOCYTE COUNT; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MENINGITIS, BACTERIAL; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE;

EID: 0344701073     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00052-5     Document Type: Article

References (44)

1. Arditi M., Zhou J., Dorio R., Rong G.W., Goyert S.M., Kim K.S. Endotoxin-mediated endothelial cell injury and activation Role of soluble CD14 . Infect. Immun. 61:1993;3149-3156.
2. Billiar T.R. Nitric oxide Novel biology with clinical relevance . Ann. Surg. 221:1995;339-349.
3. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
4. Boje K.M.K. Cerebrovascular permeability changes during experimental meningitis in the rat. J. Pharmacol. Exp. Ther. 274:1995;1199-1203.
5. Boje K.M.K. Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Eur. J. Pharmacol. 272:1995;297-300.
6. Boje K.M.K. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res. 720:1996;75-83.
7. Buster B.L., Weintrob A.C., Townsend G.C., Scheld W.M. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63:1995;3835-3839.
8. de Vries H.E., Blom-Roosemalen M.C., de Boer A.G., van Berkel T.J., Breimer D.D., Kuiper J. Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J. Pharmacol. Exp. Ther. 277:1996;1418-1423.
9. Feinstein D.L., Galea E., Reis D.J. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60:1993;1945-1948.
10. Förstermann U., Gath I., Schwarz P., Closs E.I., Kleinert H. Isoforms of nitric oxide synthase Properties, cellular distribution and expressional control . Biochem. Pharmacol. 50:1995;1321-1332.
11. Frei K., Piani D., Pfister H.W., Fontana A. Immune-meidated injury in bacterial meningitis. Internat. Rev. Exp. Pathol. 34B:1993;183-192.
12. Haberl R.L., Anneser F., Kodel U., Pfister H.W. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis? Neurol. Res. 16:1994;108-112.
13. Haskó G., Németh Z.H., Szabó C., Zsilla G., Salzman A.L., Vizi E.S. Isoproterenol inhibits IL-10, TNF-α, and nitric oxide production in RAW 254.7 macrophages. Brain Res. Bull. 45:1998;183-187.
14. Haskó G., Szabó C., Németh Z.H., Kvetan V., Pastores S.M., Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157:1996;4634-4640.
15. Haskó G., Szabó C., Németh Z.H., Salzman A.L., Vizi E.S. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur. J. Immunol. 28:1998;468-472.
16. Kilbourn R.G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 82:1990;772-776.
17. Koedel U., Bernatowicz A., Paul R., Frei K., Fontana A., Pfister H.W. Experimental pneumococcal meningitis cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide . Ann. Neurol. 37:1995;313-323.
18. Kornelisse R.F., Hoekman K., Visser J.J., Hop W.D.J., Huijmans J.G.M., Vanderstraaten P.J.C., Vanderheijden A.J., Sukhai R.N., Neijens H.J., Degroot R. The role of nitric oxide in bacterial meningitis in children. J. Infect. Dis. 174:1996;120-126.
19. Korytko P.J., Boje K.M.K. Pharmacological characterization of nitric oxide production in a rat model of meningitis. Neuropharmacology. 35:1996;231-237.
20. 2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha. J. Leukocyte Biol. 58:1995;217-224.
21. Mertsola J. Cytokines in the pathogenesis of bacterial meningitis. Trans. R. Soc. Trop. Med. Hyg. 85:1991;17-18.
22. Milstien S., Sakai N., Brew B.J., Krieger C., Vickers J.H., Saito K., Heyes M.P. Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem. 63:1994;1178-1180.
23. Mitchell J.A., Larkin S., Williams T.J. Cyclooxygenase-2 Regulation and relevance in inflammation . Biochem. Pharmacol. 50:1995;1535-1542.
24. Muller J.M., Loms Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 187:1993;233-256.
25. Mustafa M.M., Ramilo O., Sáez-Llorens X., Olsen K.D., Magness R.R., McCracken G.H. Cerebrospinal fluid prostaglandins, interleukin 1, and tumor necrosis factor in bacterial meningitis. Am. J. Dis. Child. 144:1990;883-887.
26. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109-119.
27. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J. Clin. Invest. 87:1991;1360-1366.
28. Roos K.L. The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis. Clin. Neuropharmacol. 18:1995;138-147.
29. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:1993;7240-7244.
30. 2. Prostaglandins Leukot. Essent. Fatty Acids. 47:1992;105-110.
31. Sharief M.K., Ciardi M., Thompson E.J. Blood-brain barrier damage in patients with bacterial meningitis Association with tumor necrosis factor-alpha but not interleukin-1 beta . J. Infect. Dis. 166:1992;350-358.
32. Skaper S.D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64:1995;266-276.
33. Skultétyová I., Tokarev D., Jezová D. Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats. Brain Res. Bull. 45:1998;175-178.
34. Smith W.L., Meade E.A., DeWitt D.L. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2. Ann. N.Y. Acad. Sci. 714:1994;136-142.
35. Spellerberg B., Tuomanen E.I. The pathophysiology of pneumococcal meningitis. Ann. Med. 26:1994;411-418.
36. Swierkosz T.A., Mitchell J.A., Warner T.D., Botting R.M., Vane J.R. Co-induction of nitric oxide synthase and cyclo-oxygenase Interactions between nitric oxide and prostanoids . Br. J. Pharmacol. 114:1995;1335-1342.
37. Tetsuka T., Daphna-Iken D., Srivastava S.K., Baier L.D., DuMaine J., Morrison A.R. Cross-talk between cyclooxygenase and nitric oxide pathways Prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1 . Proc. Natl. Acad. Sci. USA. 91:1994;12168-12172.
38. Thomas D.G. Outcome of paediatric bacterial meningitis 1979-1989. Med. J. Australia. 157:1992;519-520.
39. Tunkel A.R., Scheld W.M. Pathogenesis and pathophysiology of bacterial meningitis. Ann. Rev. Med. 44:1993;103-120.
40. Tuomanen E. Adjunctive therapy of experimental meningitis Agents other than steroids . Antibiot. Chemother. 45:1992;184-191.
41. Visser J.J., Scholten R.J., Hoekman K. Nitric oxide synthesis in meningococcal meningitis. Ann. Intern. Med. 120:1994;345-346.
42. Waldman S.A., Murad F. cGMP synthesis and function. Pharmacol. Rev. 39:1987;163-196.
43. Wispelwey B., Lesse A.J., Hansen E.J., Scheld W.M. Haemophilus influenzae lipopolysaccharide-induced blood-brain barrier permeability during experimental meningitis in the rat. J. Clin. Invest. 82:1988;1339-1346.
44. Ziylan Y.Z., Robinson P.J., Rapoport S.I. Blood-brain barrier permeability to sucrose and dextran after osmotic opening. Am. J. Physiol. 247:1984;R634-R638.